Official Publications Nanobiotix

Equities

Real-time Euronext Paris Other stock markets 09:46:18 2024-04-24 am EDT			5-day change	1st Jan Change
5.625 ^EUR	-2.17%		+7.45%	-15.29%

Apr. 03	Nanobiotix completes escalation portion of 2020-0123 study	CF
Apr. 02	Nanobiotix Completes Dose Escalation Segment of Phase 1 Study Targeting Non-Small Cell Lung Cancer	MT

Combined general shareholders meeting	Apr. 21	CO
Monthly statement on voting rights	Mar. 30	CO
Monthly statement on voting rights	Mar. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Jan. 30	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Dec. 30	CO
Monthly statement on voting rights	Nov. 29	CO
Monthly statement on voting rights	Nov. 29	CO
Threshold crossings	Nov. 28	CO
3rd quarter results	Nov. 12	CO
3rd quarter results	Nov. 12	CO
Threshold crossings	Nov. 07	CO
Monthly statement on voting rights	Nov. 07	CO
Monthly statement on voting rights	Nov. 07	CO
Threshold crossings	Nov. 06	CO
Amendment to the universal registration document	Nov. 02	CO
Amendment to the universal registration document	Oct. 31	CO
Monthly statement on voting rights	23-09-29	CO
Monthly statement on voting rights	23-09-29	CO
Half-year report	23-09-25	CO
1st-half-year results	23-09-25	CO
1st-half-year results	23-09-25	CO
Threshold crossings	23-09-11	CO
Threshold crossings	23-09-05	CO